First Tracks Biotherapeutics, Inc. (TRAX)

TRAX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.03	0.05	0.04	0.04
Net Debt / Equity Ratio	-0.97	-1.03	-0.94	-0.91
Net Debt / EBITDA Ratio	0.97	1.67	2.05	3.38
Net Debt / FCF Ratio	1.32	2.08	2.93	3.98
Quick Ratio	13.91	10.05	10.65	21.45
Current Ratio	14.28	10.20	10.78	21.87
Return on Equity (ROE)	-	-48.91%	-40.85%	-
Return on Assets (ROA)	-	-28.97%	-25.55%	-
Return on Capital Employed (ROCE)	-99.30%	-59.80%	-44.60%	-26.10%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error